SCM
Stonepine Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,500,000
| Closed | -$36.8M | – | 21 |
|
|
2023
Q4 | $36.8M | Sell |
2,500,000
-15,868
| -0.6% | -$234K | 15.92% | 3 |
|
|
2023
Q3 | $46.1M | Buy |
2,515,868
+1,394,840
| +124% | +$25.5M | 15.3% | 3 |
|
|
2023
Q2 | $24.2M | Buy |
+1,121,028
| New | +$24.2M | 8.72% | 5 |
|